UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): August 1230, 2010

BIOSPHERE MEDICAL, INC.

(Exact Name of Registrant as Specified in Charter)

Delaware	000-23678	04-3216867
(State or Other Jurisdiction of	(Commission File Number)	(IRS Employer
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)
Incorporation)		Identification No.)

1050 Hingham Street Rockland, Massachusetts		02370
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s telephone number, including area code: (781) 681-7900

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 58.0701. ~~Submission~~Other ~~of Matters to a Vote of Security Holders~~Events.

On ~~August~~ June 1210, 2010, certain of the directors of BioSphere Medical, Inc. (~~the~~ “~~Company~~BioSphere”) ~~held~~were ~~its~~named as defendants in a putative class action complaint, ~~2010~~captioned ~~Annual~~Fessahaye ~~Meeting~~v. Faleschini, et al., C.A. No. 5553-CC, filed in the Court of ~~Stockholders~~Chancery (of the ~~“Annual~~State ~~Meeting”)~~of Delaware. In ~~light~~The action, purportedly brought on behalf of a class of BioSphere ~~the~~stockholders, ~~Company~~alleges that certain of BioSphere’s ~~previously~~directors ~~announced~~purportedly breached ~~execution~~their offiduciary aduties ~~definitive~~in ~~agreement~~connection ~~and~~with ~~plan of~~the proposed merger with Merit Medical Systems, Inc. ~~(“Merit”)~~by ~~and~~failing ~~Merit~~to maximize shareholder value and ~~BioAcquisition~~obtain Cothe best financial and other terms., aThe ~~wholly-owned~~complaint ~~subsidiary~~includes ofrequests ~~Merit~~for declaratory, ~~the~~injunctive ~~Company~~and ~~determined~~other equitable relief, including enjoining toBioSphere ~~further~~from ~~adjourn~~consummating the ~~Annual~~proposed ~~Meeting~~merger, in addition to fees and costs. AsOn aJuly 19, ~~result~~2010, ~~the~~plaintiff ~~sole~~filed ~~order~~an ~~of business~~amended atcomplaint ~~the~~adding BioSphere ~~Annual~~Medical, Inc. ~~Meeting~~as ~~was~~ a ~~vote~~defendant onand ~~the~~further ~~proposal~~alleging tothat ~~adjourn the Annual~~BioSphere’s ~~Meeting~~preliminary ~~until~~proxy ~~September 10,~~statement ~~2010,~~failed atto ~~11:00~~provide ~~Eastern~~material ~~Daylight~~information ~~Time,~~and ~~at the~~provided ~~offices~~materially ofmisleading ~~WilmerHale,~~information inrelating ~~Boston,~~to ~~Massachusetts~~the proposed merger.

~~The~~Although ~~final~~the ~~number~~defendants continue to deny liability with respect to the claims alleged in the action, on August 30, 2010, plaintiff (on behalf of ~~votes~~himself ~~cast~~and ~~for~~the members of the putative class) and all defendants entered into a definitive agreement to settle the litigation. The definitive settlement agreement is subject to approval by the Court and, ~~against~~if orapproved, ~~abstaining~~will ~~from~~result ~~voting~~in ondismissal ~~that~~of ~~proposal~~all ~~are~~of ~~listed~~the ~~below:~~claims in the lawsuit. The final settlement hearing is currently scheduled for November 4, 2010.

Proposal — To approve an adjournment of the 2010 Annual Meeting of Stockholders until September 10, 2010, at 11:00 a.m. Eastern Daylight Time at the offices of WilmerHale in Boston, Massachusetts.2

Votes For		Votes Against		Abstain
15,822,666		0		5,322,679

SIGNATURE

2Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

SIGNATURE

Date: September 2, 2010	BIOSPHERE MEDICAL, INC.


	By:	/s/ Martin J. Joyce
		Martin J. Joyce
		Executive Vice President
		and Chief Financial Officer

~~Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.~~3

Date: August 16, 2010	BIOSPHERE MEDICAL, INC.
	By:	/s/ Martin J. Joyce
		Martin J. Joyce
		Executive Vice President and Chief Financial Officer

Filing Compare · BIOSPHERE MEDICAL INC